In a new editorial from MerckManuals.com ... visit this editorial on MerckManuals.com. About The Merck Manuals and MSD Manuals First published in 1899 as a small reference book for physicians ...

If you want to stay updated on the latest options trades for Merck & Co, Benzinga Pro gives you real-time options trades alerts.

First published in 1899, The Merck Manual for professionals is now in its 20th edition and is celebrating its 125th anniversary. The first edition of the consumer version of the book was introduced in ...

Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...

After hours: September 18 at 7:59 PM EDT Loading Chart for MRK ...

strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.

In the wake of Merck’s latest setback, the search for a viable PD-1/L1 inhibitor in stage 1 or 2 unresected NSCLC is still ongoing for at least one other company. AstraZeneca is conducting the ...

In a report released on September 11, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK ... (I-DXd), a potential new standard-of-care for second-line ...

Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts. Benzinga is an innovative financial news outlet that has become the first choice for brokerages given ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...